• $540.1M
    Market Cap
  • -28.79%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
100.3M
+53.94%
65.1M
N/A
Cost of Revenue
44.7M
+52.94%
29.2M
N/A
Gross Profit
55.5M
+54.75%
35.9M
N/A
Sales and Marketing Expense
61.4M
+65.57%
37.1M
N/A
Research and Development Expense
-34.8M
+32.86%
-26.2M
N/A
Depreciation and Amortization Expense
1.6M
+36.66%
1.2M
N/A
Total Operating Expenses
127.2M
+56.79%
81.1M
N/A
Operating Profit
-71.7M
+58.41%
-45.3M
N/A
Interest Income
10.9M
+179.66%
3.9M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
10.9M
+179.66%
3.9M
N/A
Total Nonoperating Income and Expense
-1.5M
-84.02%
-9.5M
N/A
Income before Taxes
-71.7M
+58.41%
-45.3M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-73.2M
+33.68%
-54.8M
N/A
Net Income from Continuing Operations Applicable to Common
-73.2M
+33.68%
-54.8M
N/A
Basic EPS and Net Income
-1.81
-78.95%
-8.60
N/A
Diluted EPS and Net Income
-1.81
-78.95%
-8.60
N/A
Basic Weighted Average Shares
40.5M
+536.74%
6.4M
N/A
Diluted Weighted Average Shares
40.5M
+536.74%
6.4M
N/A
Balance Sheet
Cash and Cash Equivalents
31.6M
+3.76%
30.4M
N/A
Short-Term Investments
187.5M
+156.41%
73.1M
N/A
Cash and Cash Equivalents and Short-Term Investments
219.1M
+111.56%
103.6M
N/A
Total Current Assets
267.9M
+101.55%
132.9M
N/A
Accumulated Depreciation
5.8M
+9.56%
5.3M
N/A
Property and Plant and Equipment and Net
8.6M
+80.07%
4.8M
N/A
Total Long-Term Assets
180,000
+20.00%
150,000
N/A
Total Assets
328.7M
+119.68%
149.6M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
100,000
0.00%
100,000
N/A
Total Current Liabilities
30.9M
+46.23%
21.1M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
1.5M
-97.05%
52.5M
N/A
Total Liabilities
41.1M
-44.14%
73.6M
N/A
Retained Earnings
-369.9M
+24.67%
-296.7M
N/A
Total Stockholders Equity
287.6M
+217.22%
-245.4M
N/A
Total Shares Outstanding
44.4M
+1,409.34%
2.9M
N/A
Cash Flow
Cash from Operating Activities
-50.9M
+5.49%
-48.3M
N/A
Capital Expenditures
5.3M
+56.02%
3.4M
N/A
Cash from Investing Activities
-162.8M
+4,583.69%
-3.5M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
214.9M
+286.36%
55.6M
N/A
Financials Ratio
Gross Margin
55.40%
N/A
N/A
N/A
Operating Margin
-71.50%
N/A
N/A
N/A
Return on Assets
-30.60%
N/A
N/A
N/A
Return on Equity
-346.51%
N/A
N/A
N/A
Revenue Growth
53.94%
N/A
N/A
N/A
Current Ratio
8.66
N/A
N/A
N/A
Cash Ratio
1.02
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow